Colfax Corporation Form 10-K Summary
Scope note: The supplied filing is for Colfax Corporation, not Enovis Corporation, and covers the fiscal year ended December 31, 2013. It is not a standalone 2013 Q4 filing, although fourth-quarter data is included. The filing was signed February 12, 2014.
Business Context and Reporting Period
Colfax was a diversified global industrial manufacturer operating through two reportable segments: Gas and Fluid Handling, marketed primarily under Howden and Colfax Fluid Handling brands, and Fabrication Technology, marketed primarily under ESAB. Products served power generation, oil and gas, petrochemical, mining, marine, defense, general industrial, welding and cutting markets.
The company emphasized organic growth, acquisitions and continuous-improvement initiatives under the Colfax Business System. Approximately 80% of 2013 sales were derived from operations outside the United States, and approximately 53% of sales were shipped to developing countries.
Key Financial Metrics
| Metric | 2013 | 2012 | Change |
|---|---|---|---|
| Net sales | $4.207 billion | $3.914 billion | 7.5% increase |
| Gross profit | $1.306 billion | $1.152 billion | 13.4% increase |
| Gross margin | 31.0% | 29.4% | Up 160 basis points |
| Operating income | $406.4 million | $140.0 million | Increase |
| Net income | $209.1 million | $(42.3) million | Returned to profitability |
| Net income available to common shareholders | $158.2 million | $(83.4) million | Returned to profitability |
| Diluted EPS | $1.54 | $(0.92) | Improved |
| Cash flow from operations | $362.2 million | $174.0 million | 108.1% increase |
| Capital expenditures | $71.5 million | $83.2 million | Decrease |
| Cash and cash equivalents | $311.3 million | $482.4 million | Decrease of $171.1 million |
| Total debt | $1.487 billion | $1.728 billion | Decrease of $241.2 million |
Gas and Fluid Handling generated $2.104 billion of sales and $270.7 million of segment operating income, producing a 12.9% segment margin versus 7.4% in 2012. Fabrication Technology generated $2.103 billion of sales and $219.6 million of segment operating income, producing a 10.4% margin versus 7.0% in 2012.
Gas and Fluid Handling backlog was approximately $1.6 billion at December 31, 2013, compared with $1.4 billion at December 31, 2012. Orders for that segment increased 3.3% to approximately $2.061 billion.
Material Changes Versus the Prior Comparable Period
- Sales growth of $293.3 million consisted primarily of $246.9 million from acquisitions and $107.5 million from existing businesses, partly offset by $61.1 million of unfavorable foreign-currency translation.
- Operating income benefited from higher volumes, cost controls, lower acquisition-related amortization and reduced restructuring and asbestos litigation expenses.
- Gross margin improved primarily because 2012 acquisition-related inventory step-up costs did not recur and fabrication technology benefited from cost reductions and favorable pricing relative to raw-material costs.
- 2013 acquisitions included Fläkt Woods Group’s global infrastructure and industry division, CKD Kompresory, TLT-Babcock, Alphair, Clarus and the remaining ownership of Sicelub. The company also increased its ownership of Soldex from approximately 91% to 99%.
- Acquisition cash outflows were $372.5 million, while the 2012 Charter acquisition had generated approximately $1.86 billion of acquisition-related investing cash outflows.
- Interest expense increased to $103.6 million, including a $29.4 million write-off of deferred financing fees and original issue discount associated with debt amendments.
- Research and development expense increased to $27.4 million from $19.4 million.
Guidance, Outlook, Risks and Unusual Items
Management expected long-term organic growth from expanded product offerings and customer reach, supported by a balanced mix of long- and short-cycle businesses, developed and emerging markets, and foremarket and aftermarket products. Management did not provide specific consolidated financial guidance and stated that individual businesses monitor customers, competitors and general economic trends.
Key execution priorities included integrating acquisitions, applying the Colfax Business System to improve margins and working capital, rationalizing assets and back-office functions, and consolidating manufacturing facilities. The company expected approximately $50 million of restructuring charges during 2014.
- Debt and liquidity: Debt was primarily variable-rate under the Deutsche Bank Credit Agreement. The weighted-average borrowing rate was 1.99% at year-end, and $560.6 million remained available on revolving facilities. The company stated that liquidity was adequate for the next twelve months and was in compliance with debt covenants.
- Debt covenants: The credit agreement restricted additional debt, dividends, repurchases, investments, liens, mergers and asset dispositions. The agreement required a maximum total leverage ratio of 4.95-to-1.0 for 2013 and a minimum interest coverage ratio of 2.25-to-1.0, with stricter future thresholds.
- Asbestos: Asbestos liabilities totaled $409.4 million and asbestos insurance assets totaled $395.3 million. Estimates covered approximately 15 years; future costs beyond that period were not accrued. Insurance coverage litigation remained unresolved, and temporary funding needs could reach $10 million per quarter for one subsidiary.
- Pensions: Defined benefit and other post-retirement plans were underfunded by approximately $301.9 million in aggregate at year-end. Expected 2014 contributions were $71.7 million.
- Foreign exchange: Venezuela’s currency devaluation resulted in a $2.9 million transaction loss. Management expected additional translation losses in the first quarter of 2014 from Argentina’s currency devaluation.
- Tax and international cash: $290.2 million of cash was held outside the United States and could be subject to tax and other restrictions if repatriated. The company had $358.4 million of valuation allowances against deferred tax assets and $68.8 million of net unrecognized tax benefits.
- Other commitments: Outstanding letters of credit were $398.2 million, purchase obligations were $433.4 million, and future operating lease payments were $157.2 million.
- Unusual quarterly items: Fourth-quarter 2013 net income included a $13.8 million gain from remeasuring the Sicelub investment to fair value, while interest expense included a $26.8 million debt-financing write-off.
Most Important Facts for Investors to Verify
- Confirm that the intended issuer is Colfax Corporation rather than Enovis Corporation and that the intended period is the 2013 fiscal year rather than a standalone fourth quarter.
- Review the sustainability of operating-margin expansion after excluding acquisition, restructuring, foreign-exchange and debt-refinancing items.
- Assess acquisition integration, particularly the 2013 fan, compressor, service and Sicelub acquisitions and the continuing effects of the 2012 Charter acquisition.
- Evaluate debt maturity, covenant headroom, variable-rate exposure and available revolving capacity.
- Reassess asbestos liabilities and insurance recoveries, including unresolved coverage litigation and insurer solvency.
- Review pension funding requirements, international cash restrictions, tax valuation allowances and uncertain tax positions.
- Monitor foreign-currency exposure, especially Venezuela and Argentina, and the effect of currency movements on reported sales, earnings and equity.
- Consider the concentration of goodwill and intangible assets, which totaled approximately $3.217 billion and remained subject to impairment risk.